Prasol Chemicals Q2 FY27 Revenue Up 38.6% YoY

The document is a regulatory filing containing the transcript of a Quarterly Earnings Conference Call held to discuss the Q2 FY27 results. The event was a post-results investor interaction.
The call was held on Tuesday, November 03, 2026. A specific time was not mentioned in the provided transcript.
The stated purpose of the event was to discuss the company's Q2 FY27 and H1 FY27 financial results and provide a business update, including progress on expansion plans.
The meeting was scheduled after the earnings announcement, as it refers to a prior letter dated October 29, 2026, and discusses the results in detail.
Management participants included:
Mr. Nishith Shah – Chairman and Whole-Time Director
Mr. Dhaval Parikh – Joint Managing Director
Mr. Pankil Dharia – Whole-Time Director
Mr. Rahul Shroff – Chief Financial Officer
The moderator was Mr. Karan Talwar from DAM Capital Advisors.
The transcript was made available and uploaded on the company's website at https://www.prasolchem.com/investorrelations/ as per SEBI LODR Regulations.
The transcript includes a standard disclaimer: "E&OE - This transcript is edited for factual errors. In case of discrepancy, the audio recordings uploaded on the stock exchange on 3 rd November 2026 will prevail." The company did not include a specific compliance statement regarding UPSI in this transcript.

Financial Period & Guidance:

The call discussed Q2 FY27 and H1 FY27 results.
Q2 FY27 Financials: Revenue stood at INR 413 crores (YoY growth of 38.6%), EBITDA was INR 58 crores (YoY growth of 86.1%), and PAT was INR 38 crores (YoY growth of 122.2%).
H1 FY27 Financials: Revenue stood at INR 846 crores (YoY growth of 37.1%), EBITDA was INR 148 crores (YoY growth of 106%, includes Q1 exceptional gain of INR 25 cr and forex gain of INR 0.92 cr), and PAT was INR 99 crores (YoY growth of 138.9%).
Management reaffirmed its full-year FY27 guidance: Revenue of INR 1,550-1,650 crores and EBITDA of INR 240-250 crores, which excludes the Q1 inventory gain of INR 25 crores.
A forward-looking strategic theme was the goal to scale the business to INR 2,800-3,000 crores in the coming 5 years.

The document is the enclosed transcript of the conference call, filed as an attachment to the stock exchanges.
Financial data was extensively disclosed in the announcement, including revenue, EBITDA, PAT, working capital metrics, and capex details for Q2 and H1 FY27.